ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
4,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
4,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
5,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
7,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
8,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
8,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
8,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
9,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
9,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
11,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
12,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
12,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
13,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
14,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
14,3,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
14,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
15,1,Discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
15,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
15,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
16,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
16,2,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
17,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
17,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
17,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
17,4,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
18,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
18,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
18,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
18,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,5,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
19,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
19,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
19,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
20,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
20,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
20,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
21,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
21,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
22,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
22,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
23,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
24,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
24,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
24,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
24,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
24,5,Skin discharge,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
24,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
25,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
25,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
25,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
26,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
26,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
26,3,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
27,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
27,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
27,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
27,4,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
28,1,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
29,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
29,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
29,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
30,1,Acne,Acnes,Skin appendage conditions,Skin,N
30,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
